Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaire

References

• American Cancer Society. Global cancer facts and figures. 2nd edn. Atlanta: American Cancer Society; 2011. Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-027766.pdf (accessed 2013 January 25)..
   Google Scholar
• Lumen N, Fonteyne V, De Meerleert G, Ost P, Villeirs G, Mottrie A, et al. Population screening for prostate cancer: an overview of available studies and meta-analysis. Int J Urol. 2012;19(2):100–8.
   PubMed Web of Science ®Google Scholar
• Lumen N, Fonteyne V, De Meerleer G, De Visschere P, Ost P, Oosterlinck W, et al. Screening and early diagnosis of prostate cancer: an update. Acta Clin Belg. 2012;67(4):270–5.
   PubMed Web of Science ®Google Scholar
• Gwede CK, Pow-Sang J, Seigne J, Heysek R, Helal M, Shade K, et al. Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer. 2005;104(7):1381–90.
   PubMed Web of Science ®Google Scholar
• Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65(1):124–37.
   PubMed Web of Science ®Google Scholar
• Sun M, Sammon JD, Becker A, Roghmann F, Tian Z, Kim SP, et al. Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation. BJU Int. 2014;113(2):200–8.
   PubMed Web of Science ®Google Scholar
• Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, et al. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int. 2012;109(Suppl 1):22–9.
   PubMed Web of Science ®Google Scholar
• Anandadas CN, Clarke NW, Davidson SE, O'Reilly PH, Logue JP, Gilmore L, et al. Early prostate cancer – which treatment do men prefer and why? BJU Int. 2011;107(11):1762–8.
   PubMed Web of Science ®Google Scholar
• RAND Corporation. Delphi method. Available from: http://www.rand.org/topics/delphi-method.html (accessed 2012 March 12)..
   Google Scholar
• Van Praet C, Decaestecker K, Fonteyne V, Ost P, De Visschere P, Verschuere S, et al. Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complications. Int J Urol. 2014;21(11):1138–43.
   PubMed Web of Science ®Google Scholar
• Roach M 3rd, Marquez C, Yuo HS, Narayan P, Coleman L, Nseyo UO, et al. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1994;28(1):33–7.
   PubMed Web of Science ®Google Scholar
• Zeliadt SB, Ramsey SD, Penson DF, Hall IJ, Ekwueme DU, Stroud L, et al. Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer. 2006;106(9):1865–74.
   PubMed Web of Science ®Google Scholar
• Feldman-Stewart D, Brundage MD, Tong C. Information that affects patients' treatment choices for early stage prostate cancer: a review. Can J Urol. 2011;18(6):5998–6006.
   PubMed Web of Science ®Google Scholar
• de Bekker-Grob EW, Bliemer MC, Donkers B, Essink-Bot ML, Korfage IJ, Roobol MJ, et al. Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment. Br J Cancer. 2013;109(3):633–40.
   PubMed Web of Science ®Google Scholar
• Aning JJ, Wassersug RJ, Goldenberg SL. Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret. Curr Oncol. 2012;19(Suppl 3):S37–S44.
   Google Scholar
• Punnen S, Cooperberg MR, D'Amico AV, Karakiewicz PI, Moul JW, Scher HI, et al. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature. Eur Urol. 2013;64(6):905–15.
   PubMed Web of Science ®Google Scholar
• Stephenson AJ, Bolla M, Briganti A, Cozzarini C, Moul JW, Roach M 3rd, et al. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur Urol. 2012;61(3):443–51.
   PubMed Web of Science ®Google Scholar
• Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007;25(15):2035–41.
   PubMed Web of Science ®Google Scholar